Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Southport, Australia.
Frequently asked questions
What sector does Epsilon Healthcare Limited (HDRPF) operate in?
Epsilon Healthcare Limited belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Epsilon Healthcare Limited (HDRPF) current stock price?
As of the latest data, Epsilon Healthcare Limited stock price is $0.01, with a previous close of $0.01.
What is Epsilon Healthcare Limited (HDRPF) current market capitalization?
Epsilon Healthcare Limited market cap is approximately 3.89 million.
What is Epsilon Healthcare Limited (HDRPF) EBITDA?
Epsilon Healthcare Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -724.62 thousand.
Does Epsilon Healthcare Limited (HDRPF) pay dividends?
No. Epsilon Healthcare Limited does not pay a dividend.
What is Epsilon Healthcare Limited (HDRPF) beta (volatility) score?
Epsilon Healthcare Limited has a beta of 0.629, indicating lower volatility than the overall market.